Press

NuCurrent to Sponsor and Present at IDTechEx Show

November 3, 2017

Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy

October 30, 2017

Sierra Oncology Appoints Dr. Andrew Allen to its Board of Directors

October 25, 2017

Hologram Releases Nova, an Open Source Cellular Modem for Cellular IoT

October 5, 2017

NuCurrent Named a 2017 Fourth Revolution Awards Finalist

September 22, 2017

Preparing for (and Profiting from) Apple's Wireless World [NuCurrent]

September 19, 2017

NuCurrent Appoints New Vice President of Engineering

September 19, 2017

NuCurrent Named a 2017 Chicago Innovation Awards Finalist

September 14, 2017

NuCurrent Named a 2017 Timmy Awards Finalist

August 29, 2017

How Intellihot Is Making Boiler Rooms Smarter

August 15, 2017

NuCurrent Named a 2017 ITA CityLIGHTS Awards Finalist

August 9, 2017

NuCurrent Appoints New Vice President of Operations

July 25, 2017

HarQen moves company headquarters to Brookfield

July 18, 2017

NuCurrent Named 2017 FLEXI Awards Winner

June 22, 2017

Sierra Oncology Reports Encouraging Initial Progress from Ongoing Phase 1 Clinical Trials of Chk1 Inhibitor SRA737

June 5, 2017

Sierra Oncology Granted US and EU Patents for Chk1 inhibitor SRA737

May 30, 2017

Sierra Oncology Receives Clearance to Enhance Ongoing Clinical Trials for SRA737

May 10, 2017

Turn Up the Heat [Intellihot]

April 4, 2017

Sierra Oncology Collaborator ICR Reports Preclinical Synthetic Lethality Data for Chk1 Inhibitor SRA737 at AACR

April 3, 2017

Large demand met with small footprint [Intellihot]

March 29, 2017

Turn up the heat with reliability [Intellihot]

March 27, 2017

2017 AHR Expo - Intellihot's connected devices offer an altogether better system

March 27, 2017

Next-generation deionized tankless water heaters [Intellihot]

March 21, 2017

Gemphire Therapeutics Announces $12.5 Million Financing

March 10, 2017

Sierra Oncology Announces Pricing of Public Offering of Common Stock

February 9, 2017

Gemphire Announces Interim LDL-C Lowering Data from COBALT-1 Phase 2b Clinical Trial

January 30, 2017

ONKÖL Nominated for Prestigious GSMA "Glomo" Award

January 30, 2017

Intelligent additions [Intellihot]

January 16, 2017

Sierra Oncology Successfully Transfers Sponsorship of SRA737 Clinical Trials

January 9, 2017

ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs

January 9, 2017

Gemphire Announces Positive Results for Gemcabene in Proof-of-Concept NASH Preclinical Study

January 9, 2017

Gemphire Therapeutics Provides Clinical Update

January 5, 2017

Contact

10556 N Port Washington Rd
Ste 201
Mequon, WI 53092

(414) 453-4488